The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma

PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide and irinotecan for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGNS: Seventy five patients with newly diagnosed glioblastoma were enrolle...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Vredenburgh, James J., Desjardins, Annick, Reardon, David A., Peters, Katherine B., Herndon, James E., Marcello, Jennifer, Kirkpatrick, John P., Sampson, John H., Bailey, Leighann, Threatt, Stevie, Friedman, Allan H., Bigner, Darell D., Friedman, Henry S.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117928/
https://ncbi.nlm.nih.gov/pubmed/21531816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0120
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы